ERBB2 and neoplasm: Tobias et al. (2020) showed enhanced vaccine’s anti-tumour effect in mouse models with the combination of HER-Vaxx (which comprises 3 fused single peptides from ECD of Her-2/neu) and anti-PD-1 blockade [144,145].